Cecropin P1

General Information


DRACP ID  DRACP01077

Peptide Name   Cecropin P1

Sequence  SWLSKTAKKLENSAKKRISEGIAIAIQGGPR

Sequence Length  31

UniProt ID  P14661 

PubChem CID  Not available

Origin  Small Intestine of Pig

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
K562 Blast phase chronic myelogenous leukemia, BCR-ABL1 positive; Chronic myeloid leukemia Leukemia IC50=93 µM MTT assay 96 h 1
BTS-30 Breast Cancer Carcinoma IC50>100 µM MTT assay 96 h 1
HRT-18 Colon adenocarcinoma Carcinoma IC50>100 µM MTT assay 96 h 1
DLD-1 Colon adenocarcinoma Carcinoma IC50>100 µM MTT assay 96 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  2N92 

Predicted Structure  DRACP01077

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C147H253N45O43

Absent amino acids  CDFHMVY

Common amino acids  K

Mass  387419

Pl  11.34

Basic residues  7

Acidic residues  2

Hydrophobic residues  11

Net charge  5

Boman Index  -5765

Hydrophobicity  -55.81

Aliphatic Index  88.39

Half Life 
  Mammalian: 30 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  183.33

Polar residues  9

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 7849420

Title  Preliminary experimental anticancer activity of cecropins

Doi Not available

Year  1994

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.